Critical Facts About Bath & Body Works - You Won't Regret Reading This.

By Blake Campbell • Friday, October 28 09:41 • Permanent Link

Mid-cap Consumer Cyclical company Bath & Body Works has moved 0.9% so far today on a volume of 60,744, compared to its average of 3,549,734. In contrast, the S&P 500 index moved 0.7%

Below are some factors that could be affecting the stocks's performance and analyst recommendation:

Bath & Body Works has moved -51.8% over the last year, and the S&P 500 logged a change of -17.3%
Based on its trailing earning per share of 4.02, Bath & Body Works has a trailing 12 month Price to Earnings (P/E) ratio of 8.4 while the S&P 500 average is 15.97
BBWI has a forward P/E ratio is 9.3 based on its forward 12 month price to earnings (Eps) is $4.02 per share
The company has a price to earnings growth (PEG) ratio of 1.14 -- a number near or below 1 signifying that Bath & Body Works is fairly valued compared to its estimated growth potential

Bath & Body Works, Inc. operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. Based in Columbus, the company has 8,800 full time employees and a market cap of $7,680,218,112. Bath & Body Works currently returns an annual dividend yield of 2.1%.

If you would like more in-depth discussions of stocks such as Bath & Body Works, subscribe to our free newsletter!

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.